
Sensorion submits UK clinical trial authorization application for OTOF-GT, its most advanced gene therapy product
By Claude Leguilloux Published on 07/10/2023 at 07:46 (Boursier.com) — Sensorion a pioneering clinical-stage biotechnology company dedicated to developing innovative therapies to restore, treat and prevent hearing loss, today announces that it has submitted an initial Clinical Trial Authorization Application (CTA) for…